Total Eyecare P.c. Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 Bernhardt Rd, Laurel, MT 59044 Phone: 406-628-1767 Fax: 406-628-1769 |
Dr. Gary A. White, Optometrist, Pc Optometrist Medicare: Not Enrolled in Medicare Practice Location: 101 Bernhardt Rd, Laurel, MT 59044 Phone: 406-628-1767 Fax: 406-628-1739 |
Southern Montana Optometric Center, Inc Optometrist Medicare: Medicare Enrolled Practice Location: 210 1st Ave, Laurel, MT 59044 Phone: 406-628-8668 Fax: 406-628-8668 |
Dr. Ronald Lee Benner, O.D. Optometrist Medicare: Accepting Medicare Assignments Practice Location: 210 1st Ave, Laurel, MT 59044 Phone: 406-628-8668 Fax: 406-628-8668 |
News Archive
A team of international researchers have found 32 new genetic regions linked to fractures and osteoporosis. According to the new study published in the April 15 online edition of Nature Genetics, changes in these regions could offer protection from, or greater risk for, bone-weakening disease.
Unfortunately, studies show that only about 5 million people living with OAB seek care from a doctor, and only half of those patients seek a specialist like a urologist or urogynecologist for treatment. It's time to see a doctor if you're using multiple leakage pads per day, not doing things you like because of the fear of leakage, planning all your travel around bathroom locations, or are worried about the problem every day.
In another installment in NPR's summer-long series "Beginnings," NPR's All Things Considered aired a story on Wednesday examining how the controversial drug misoprostol is being used worldwide to save women's lives.
PharmAthene, Inc., a biodefense company specializing in the development and commercialization of medical countermeasures against biological and chemical threats, and Avecia Biologics Limited, a contract manufacturer of biopharmaceuticals, has announced that the companies have entered into a definitive sale and purchase agreement under which PharmAthene will acquire all of the assets and intellectual property related to Avecia's biodefense vaccines business.
› Verified 7 days ago